Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Whitefort Capital Management

Latest statistics and disclosures from Whitefort Capital Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are GSL, ABUS, ROIV, LSXMK, GNW, and represent 76.09% of Whitefort Capital Management's stock portfolio.
Added to shares of these 7 stocks: ROIV (+$8.4M), GNW, GSL, LQDA, VATE, MHLD, Trinity Biotech.
Started 1 new stock position in Trinity Biotech.
Reduced shares in these 6 stocks: NN (-$8.7M), CEE, ESPR, ABUS, Esperion Therapeutics Inc Ne, Trinity Biotech.
Sold out of its positions in CEE, ESPR, Trinity Biotech.
Whitefort Capital Management was a net seller of stock by $-439k.
Whitefort Capital Management has $164M in assets under management (AUM), dropping by 4.66%.
Central Index Key (CIK): 0001884931

Tip: Access up to 7 years of quarterly data

Positions held by Whitefort Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Whitefort Capital Management

Whitefort Capital Management holds 19 positions in its portfolio as reported in the March 2024 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Global Ship Lease Com Cl A (GSL)	24.4	$40M	+4%	2.0M	20.30	View chart
Arbutus Biopharma (ABUS)	20.2	$33M	-2%	13M	2.58	View chart
Roivant Sciences SHS (ROIV)	15.4	$25M	+50%	2.4M	10.54	View chart
Liberty Media Corp Del Com Lbty Srm S C (LSXMK)	8.3	$14M		456k	29.71	View chart
Genworth Finl Com Cl A (GNW)	7.8	$13M	+31%	2.0M	6.43	View chart
Nextnav Common Stock (NN)	5.2	$8.5M	-50%	1.3M	6.58	View chart
Liberty Media Corp Del Com Lbty Liv S C (LLYVK)	3.0	$5.0M		114k	43.82	View chart
Liquidia Corporation Com New (LQDA)	3.0	$5.0M	+45%	338k	14.75	View chart
Sabre Glbl Note 4.000% 4/1 (Principal)	2.9	$4.7M		5.0M	0.94	View chart
Maiden Holdings SHS (MHLD)	2.8	$4.6M	+4%	2.0M	2.25	View chart
Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)	2.0	$3.3M	-18%	4.0M	0.83	View chart
Odyssey Marine Expl Com New (OMEX)	1.3	$2.1M		549k	3.81	View chart
Innovate Corp Note 7.500% 8/0 (Principal)	1.1	$1.9M		5.7M	0.33	View chart
Pitney Bowes (PBI)	1.0	$1.6M		374k	4.33	View chart
Innovate Corp (VATE)	0.8	$1.4M	+82%	2.0M	0.70	View chart
Nextnav *w Exp 99/99/999 (NNAVW)	0.6	$1.0M		483k	2.10	View chart
Trinity Biotech Spons Adr New	0.1	$167k	NEW	82k	2.04	View chart
Altenergy Acquisition Corp *w Exp 10/29/202 (AEAEW)	0.0	$9.3k		186k	0.05	View chart
Lanvin Group Holdings Limite *w Exp 01/14/202 (LANV.WS)	0.0	$5.0k		100k	0.05	View chart

Past Filings by Whitefort Capital Management

SEC 13F filings are viewable for Whitefort Capital Management going back to 2021

Whitefort Capital Management 2024 Q1 filed May 15, 2024
Whitefort Capital Management 2023 Q4 filed Feb. 14, 2024
Whitefort Capital Management 2023 Q3 filed Nov. 14, 2023
Whitefort Capital Management 2023 Q2 filed Aug. 14, 2023
Whitefort Capital Management 2023 Q1 filed May 12, 2023
Whitefort Capital Management 2022 Q4 filed Feb. 14, 2023
Whitefort Capital Management 2022 Q3 filed Nov. 14, 2022
Whitefort Capital Management 2022 Q2 filed Aug. 10, 2022
Whitefort Capital Management 2022 Q1 filed May 13, 2022
Whitefort Capital Management 2021 Q4 filed Feb. 14, 2022

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z